戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 damycin is increasingly used to treat canine pyoderma.
2 r 1000 person-years (212-327) for S pyogenes pyoderma.
3 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte c
4 tion vaccine were strongly protected against pyoderma and bacteremia, as evidenced by a 100-1000-fold
5 st common microorganism isolated from canine pyoderma and postoperative wound infections.
6     In this rheumatic fever-endemic setting, pyoderma and skin carriage represent an important S. pyo
7 we show that the vaccine can protect against pyoderma and subsequent bacteremia caused by multiple GA
8 8-36.0]), with the highest diversity seen in pyoderma and the lowest in pharyngitis.
9 primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus
10          We identified 17 pharyngitis and 99 pyoderma events and 49 pharyngeal and 39 skin S pyogenes
11 .69, 3.08-167.21), with similar findings for pyoderma (female sex: 0.34, 0.19-0.61; age <5 years: 7.0
12 ines for determining patient eligibility for pyoderma gangrenosum (PG) clinical trials.
13                                              Pyoderma Gangrenosum (PG) is a cutaneous condition, its
14                                              Pyoderma gangrenosum (PG) is a neutrophilic dermatosis o
15                                              Pyoderma gangrenosum (PG) is a rare neutrophilic dermato
16                                              Pyoderma gangrenosum (PG) is an important disease with s
17                                              Pyoderma gangrenosum (PG) is an inflammatory condition c
18             Unlike erythema nodosum (EN) and pyoderma gangrenosum (PG), LCV requires biopsy for diagn
19                                   Peristomal pyoderma gangrenosum (PPG), an unusual variant of pyoder
20  abdominal wall lesions were suspected to be pyoderma gangrenosum although biopsies were equivocal.
21 e in which cutaneous manifestations, such as pyoderma gangrenosum and acne fulminans, predominated.
22 arthritis and less frequently accompanied by pyoderma gangrenosum and acne.
23 mic inflammatory disease; pyogenic arthritis pyoderma gangrenosum and acne; Muckle-Wells syndrome; fa
24 from patients with Sweet's syndrome (SW) and pyoderma gangrenosum and found numerous novel splice var
25 reduced in tissue samples from patients with pyoderma gangrenosum and healthy controls.
26  functions of PSTPIP1 in the pathogenesis of pyoderma gangrenosum and suggest that the cytoskeleton i
27  report a case of CB, initially diagnosed as pyoderma gangrenosum and treated with steroids, leading
28  of the 157 consecutive patients treated for pyoderma gangrenosum at our institution (10 percent).
29 illation-associated disease and suggest that pyoderma gangrenosum can be classified as a dynamical di
30 gnosis of exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complicat
31 Among other entities, CB may be mistaken for pyoderma gangrenosum due to overlap of findings on histo
32 95 patients studied, 64 had been treated for pyoderma gangrenosum for a median of 10 months (range, 3
33 57 consecutive patients treated for presumed pyoderma gangrenosum from 1984 through 1992.
34             Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac
35 required in all patients suspected of having pyoderma gangrenosum in order to rule out alternative di
36                                              Pyoderma gangrenosum is a diagnosis of exclusion, and th
37                                              Pyoderma gangrenosum is an inflammatory neutrophilic der
38                                              Pyoderma gangrenosum is associated with a concomitant sy
39                          The misdiagnosis of pyoderma gangrenosum is not uncommon and exposes patient
40 ssibility that refractory celiac disease and pyoderma gangrenosum may be immunologically different.
41 s detected in all other patients with either pyoderma gangrenosum or SW, it was always associated wit
42                                            A pyoderma gangrenosum patient exhibiting aberrant leukocy
43                           Good resolution of pyoderma gangrenosum was achieved in 3 patients with tum
44 e charts of 240 patients with a diagnosis of pyoderma gangrenosum who were evaluated at our instituti
45 ter initial item deletion (Erythema nodosum, Pyoderma gangrenosum), a 7-item scale was estimated.
46                  Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604
47  dominant disease called pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.
48 to cause the syndrome of pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA), a dominantly inhe
49                          Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome)
50 generation (MRST); and a pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA).
51 ver syndrome and pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome.
52   PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne, OMIM #604416) and famili
53 e PAPA syndrome: pyogenic sterile arthritis, pyoderma gangrenosum, and acne.
54  patients with Sweet syndrome, patients with pyoderma gangrenosum, and healthy controls.
55 lymphocutaneous spread, clinically mimicking pyoderma gangrenosum, and subsequently progressed to dis
56                                              Pyoderma gangrenosum, cystic acne, and aseptic arthritis
57 rma gangrenosum (PPG), an unusual variant of pyoderma gangrenosum, has been reported almost exclusive
58 Of the ulcers in the 64 patients treated for pyoderma gangrenosum, it was clear that those in 23 pati
59 ed to other neutrophilic dermatoses, such as pyoderma gangrenosum, remain poorly understood.
60 nt) did not respond to treatment directed at pyoderma gangrenosum, those in 8 (12 percent) were exace
61 nt, rarely occurring, extra-hepatic onset of pyoderma gangrenosum, with the AIH in remission, strengt
62 port mapping of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of c
63 tion in a patient presenting with aggressive pyoderma gangrenosum.
64  samples confirmed the clinical suspicion of pyoderma gangrenosum.
65 stations included pathergy, cystic acne, and pyoderma gangrenosum.
66 ations are discussed regarding psoriasis and pyoderma gangrenosum.
67 d skin ulcers with a clinical resemblance to pyoderma gangrenosum.
68 abscesses and pretibial lesions diagnosed as pyoderma gangrenosum.
69 ic vasculitides such as Sweet's syndrome and pyoderma gangrenosum.
70 ousehold acquisitions, but skin carriage and pyoderma have an important role in S pyogenes household
71 , the frequent association of SECcanine with pyoderma in dogs supports the notion that the toxins are
72                     Incident pharyngitis and pyoderma infections were captured.
73                                              Pyoderma lesions with S pyogenes increased from 51% (127
74    The true prevalence of S pyogenes-related pyoderma may be underestimated by bacterial culture.
75 y underestimates the burden of S pyogenes in pyoderma, particularly with S aureus coinfection.
76                Integumentary infections like pyoderma represent the main reason for antimicrobial pre
77 cted to detect carriage, and pharyngitis and pyoderma swab samples were taken to assess infection.
78 us, and Sarcoptes scabiei was applied to 250 pyoderma swabs from a cross-sectional study of children
79                                              Pyoderma was the most common source of S pyogenes househ
80 were collected from skin sites (carriage and pyoderma), with evidence of skin-to-throat transmission